Alongside histology, cardiovascular magnetic resonance (CMR) is increasingly being used to aid in the diagnosis of amyloidosis based largely upon the characteristic pattern of late gadolinium enhancement and T1 mapping8–11: CMR alone cannot, however, reliably distinguish AL from ATTR subtypes. This evidence concerns the gene TTR and amyloidosis.